Insider Selling: Alignment Healthcare, Inc. (NASDAQ:ALHC) Insider Sells 10,500 Shares of Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Hakan Kardes sold 10,500 shares of Alignment Healthcare stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $14.99, for a total value of $157,395.00. Following the transaction, the insider now directly owns 309,944 shares of the company’s stock, valued at $4,646,060.56. The trade was a 3.28 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Hakan Kardes also recently made the following trade(s):

• On Friday, January 24th, Hakan Kardes sold 14,500 shares of Alignment Healthcare stock. The shares were sold at an average price of $14.98, for a total transaction of $217,210.00.
• On Wednesday, November 27th, Hakan Kardes sold 35,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $12.80, for a total transaction of $448,000.00.
• On Monday, November 4th, Hakan Kardes sold 20,500 shares of Alignment Healthcare stock. The shares were sold at an average price of $13.06, for a total transaction of $267,730.00.
• On Friday, November 1st, Hakan Kardes sold 4,500 shares of Alignment Healthcare stock. The stock was sold at an average price of $12.98, for a total value of $58,410.00.

Alignment Healthcare Price Performance

Shares of NASDAQ:ALHC opened at $14.97 on Friday. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.82. The stock has a market cap of $2.87 billion, a PE ratio of -19.44 and a beta of 1.45. The company’s fifty day moving average is $12.13 and its 200 day moving average is $11.02. Alignment Healthcare, Inc. has a 52 week low of $4.46 and a 52 week high of $15.05.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings data on Tuesday, October 29th. The company reported ($0.14) EPS for the quarter, hitting the consensus estimate of ($0.14). The firm had revenue of $692.43 million for the quarter, compared to the consensus estimate of $662.11 million. Alignment Healthcare had a negative return on equity of 108.69% and a negative net margin of 5.84%. The company’s quarterly revenue was up 51.6% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.19) earnings per share. Research analysts anticipate that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Institutional Trading of Alignment Healthcare

Hedge funds and other institutional investors have recently bought and sold shares of the stock. R Squared Ltd purchased a new position in shares of Alignment Healthcare in the fourth quarter worth $55,000. nVerses Capital LLC purchased a new position in shares of Alignment Healthcare in the third quarter valued at about $95,000. Ballentine Partners LLC bought a new position in shares of Alignment Healthcare during the fourth quarter valued at about $121,000. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in shares of Alignment Healthcare during the third quarter worth about $131,000. Finally, Creative Planning grew its stake in shares of Alignment Healthcare by 20.0% in the third quarter. Creative Planning now owns 12,442 shares of the company’s stock worth $147,000 after purchasing an additional 2,072 shares during the last quarter. Institutional investors own 86.19% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on ALHC shares. KeyCorp started coverage on Alignment Healthcare in a research note on Friday, October 11th. They issued a “sector weight” rating on the stock. UBS Group raised their target price on shares of Alignment Healthcare from $9.00 to $12.00 and gave the company a “neutral” rating in a research note on Wednesday, October 30th. Barclays boosted their price target on shares of Alignment Healthcare from $7.00 to $8.00 and gave the stock an “underweight” rating in a research note on Wednesday, October 30th. Stifel Nicolaus raised their price objective on shares of Alignment Healthcare from $14.00 to $16.00 and gave the company a “buy” rating in a research report on Tuesday, January 14th. Finally, Stephens reiterated an “overweight” rating and issued a $17.00 target price on shares of Alignment Healthcare in a research report on Thursday, January 2nd. One analyst has rated the stock with a sell rating, two have given a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, Alignment Healthcare has a consensus rating of “Moderate Buy” and an average target price of $11.88.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.